enVVeno Medical (NVNO)
(Real Time Quote from BATS)
$5.13 USD
+0.08 (1.58%)
Updated Aug 6, 2024 02:12 PM ET
3-Hold of 5 3
D Value B Growth C Momentum C VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
NVNO 5.13 +0.08(1.58%)
Will NVNO be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for NVNO based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for NVNO
enVVeno (NVNO) Plans to Expedite enVVe Development for CVI
NVNO: What are Zacks experts saying now?
Zacks Private Portfolio Services
Other News for NVNO
enVVeno Medical reports Q2 results
enVVeno Medical reports Q2 EPS (31c) vs. (58c) last year
enVVeno Medical expects capital to fund company through several milestones
enVVeno Medical Reports Second Quarter 2024 Financial Results and Provides Corporate Update
enVVeno Medical to Participate in the Virtual Investor Closing Bell Series